Dr. Frost introduces himself to us and talks about Halozyme, and how the company tries to "think outside the cell," working to "smooth out" the blood sugar rollercoaster that diabetes patients too often find themselves on. More videos with Dr. Frost: Dr. Gregory Frost Q1 What Is Halozyme’s Current Focus? Dr. Gregory Frost …

Dr. Frost talks about the background and history of Halozyme’s product development and the critical need for more effective insulins. More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do? Dr. Gregory Frost Q3 Starting Baselines and …

Dr. Frost goes over some of the details of the Halozyme study including how researchers looked at both type 1 and type 2 patients, the incidence of hypoglycemia, and the overall positive results.   More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q1 What Is Halozyme’s Current …

Dr. Frost talks about the results of the Halozyme study and the positive results, including a drop in A1c from the 8 range in type 2 diabetes patients to around 6.8. He also lets us know how the reduced use of better-designed insulins could even result in some weight loss, …

Alan Mathis, PharmD Candidate 2013, University of Florida College of Pharmacy The pathophysiology of type-2 diabetes is characterized by insulin resistance and beta-cell dysfunction. In addition, the presence of high levels of glucagon in the blood also seems to play an important role in the disease. Glucagon-like peptide-1 (GLP-1) is a …

    By Sheri Colberg, PhD   How much exercise are kids actually getting nowadays? Not nearly enough!